Merck | MRK - Le Coût Des Ventes

Prix De L'Action
120.28
Variation Quotidienne
0.45 0.38%
Mensuellement
0.44%
Annuel
29.07%
Q1 Prévisions
120.03




Le Coût Des Ventes Changement Date
AbbVie USD 4.55B 757M 2025-12
Abbott USD 4.92B 535M 2025-12
ALKERMES USD 46.21M 5.38M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 2.65M 31.2M 2025-03
Drreddys Laboratories INR 40.46B 3.64B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.01B 853.01M 2025-09
J&J USD 7.97B 689M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 217M 2025-09
Novartis USD 3.54B 216M 2025-09
Novo Nordisk DKK 15.15B 2.3B 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Phibro Animal Health USD 207.39M 30.45M 2024-12
Prestige Brands USD 131.22M 3.52M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 4.29B 421M 2025-12
Sanofi EUR 3.76B 344M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Zoetis USD 743M 60M 2025-12